Table 2 The correlation of LATS1 protein expression with Clinicopathological features in Glioma
From: Decreased expression of LATS1 is correlated with the progression and prognosis of glioma
Clinicopathological features | Cases (n) | Expression Level of LATS1 Protein(n) | P | |||
|---|---|---|---|---|---|---|
Negative | Weak | Positive | Strong | |||
Age | ||||||
≥55 | 47 | 11 | 22 | 9 | 5 |  |
< 55 | 56 | 12 | 30 | 11 | 3 | P = 0.752 |
Gender | ||||||
Male | 60 | 13 | 35 | 7 | 5 | Â |
Female | 43 | 10 | 17 | 13 | 3 | P = 0.326 |
WHO grade | ||||||
I | 19 | 1 | 6 | 8 | 4 | Â |
II | 22 | 3 | 11 | 6 | 2 | Â |
III | 30 | 7 | 19 | 3 | 1 | Â |
IV | 32 | 12 | 16 | 3 | 1 | P<0.001 |
KPS | Â | Â | Â | Â | Â | Â |
≥80 | 53 | 6 | 28 | 13 | 6 |  |
<80 | 50 | 14 | 24 | 7 | 2 | P = 0.011 |